A detailed history of Stableford Capital Ii LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stableford Capital Ii LLC holds 22,556 shares of MRK stock, worth $2.26 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
22,556
Previous 21,289 5.95%
Holding current value
$2.26 Million
Previous $2.64 Million 2.81%
% of portfolio
1.01%
Previous 1.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $140,827 - $163,404
1,267 Added 5.95%
22,556 $2.56 Million
Q2 2024

Jul 23, 2024

BUY
$123.8 - $132.96 $8,913 - $9,573
72 Added 0.34%
21,289 $2.64 Million
Q1 2024

Apr 09, 2024

SELL
$113.24 - $131.95 $66,585 - $77,586
-588 Reduced 2.7%
21,217 $2.8 Million
Q4 2023

Jan 12, 2024

SELL
$100.18 - $109.02 $45,682 - $49,713
-456 Reduced 2.05%
21,805 $2.38 Million
Q3 2023

Oct 30, 2023

BUY
$102.95 - $114.33 $58,578 - $65,053
569 Added 2.62%
22,261 $2.29 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $2.36 Million - $2.57 Million
21,692 New
21,692 $2.5 Million
Q3 2022

Oct 25, 2022

SELL
$84.53 - $94.96 $14,201 - $15,953
-168 Reduced 1.14%
14,584 $1.4 Million
Q2 2022

Oct 25, 2022

BUY
$83.49 - $94.64 $14,026 - $15,899
168 Added 1.15%
14,752 $1.29 Million
Q4 2021

Jan 28, 2022

BUY
$72.28 - $90.54 $624,354 - $782,084
8,638 Added 141.28%
14,752 $1.16 Million
Q3 2021

Oct 18, 2021

SELL
$71.68 - $78.83 $466,278 - $512,789
-6,505 Reduced 51.55%
6,114 $479,000
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $63,982 - $70,770
910 Added 7.77%
12,619 $981,000
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $8,400 - $9,895
122 Added 1.05%
11,709 $903,000
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $574,375 - $637,438
8,003 Added 223.3%
11,587 $948,000
Q1 2020

Feb 10, 2021

SELL
$63.36 - $87.82 $244,632 - $339,073
-3,861 Reduced 51.86%
3,584 $276,000
Q4 2019

Feb 10, 2021

SELL
$77.58 - $87.54 $853 - $962
-11 Reduced 0.15%
7,445 $677,000
Q3 2019

Feb 10, 2021

BUY
$76.08 - $82.93 $4,336 - $4,727
57 Added 0.77%
7,456 $628,000
Q2 2019

Feb 10, 2021

SELL
$69.84 - $81.59 $12,152 - $14,196
-174 Reduced 2.3%
7,399 $620,000
Q1 2019

Feb 10, 2021

SELL
$69.58 - $79.36 $35,972 - $41,029
-517 Reduced 6.39%
7,573 $630,000
Q4 2018

Feb 12, 2021

SELL
$65.24 - $75.71 $96,555 - $112,050
-1,480 Reduced 15.46%
8,090 $618,000
Q3 2018

Feb 10, 2021

SELL
$57.69 - $67.84 $68,881 - $81,000
-1,194 Reduced 11.09%
9,570 $679,000
Q2 2018

Feb 10, 2021

SELL
$50.83 - $59.72 $17,231 - $20,245
-339 Reduced 3.05%
10,764 $653,000
Q1 2018

Feb 10, 2021

BUY
$50.96 - $59.23 $41,685 - $48,450
818 Added 7.95%
11,103 $605,000
Q4 2017

Feb 10, 2021

BUY
$51.62 - $61.64 $37,682 - $44,997
730 Added 7.64%
10,285 $579,000
Q3 2017

Feb 10, 2021

BUY
$58.67 - $63.13 $34,849 - $37,499
594 Added 6.63%
9,555 $612,000
Q2 2017

Feb 11, 2021

SELL
N/A
-594 Reduced 6.22%
8,961 $574,000
Q2 2017

Feb 10, 2021

BUY
N/A
1,436 Added 17.69%
9,555 $612,000
Q1 2017

Feb 10, 2021

BUY
N/A
4,451 Added 121.35%
8,119 $516,000
Q4 2016

Feb 10, 2021

BUY
N/A
3,668
3,668 $216,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stableford Capital Ii LLC Portfolio

Follow Stableford Capital Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stableford Capital Ii LLC with notifications on news.